Number of the records: 1
vírusy onkolytické
SYS d050504 LBL 00000nz--a2200000o--4500 005 20250606213401.2 008 050630|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a B04.700 066 $a 01 $c 03 150 $a vírusy onkolytické $x CH $x CL $x DE $x EN $x GD $x GE $x IM $x IP $x ME $x PH $x PY $x RE $x UL $2 slo 550 $7 sllk_us_auth*d050130 $Y Oncolytic Virotherapy $w b $a viroterapia onkolytická 550 $7 sllk_us_auth*d050130 $Y Oncolytic Virotherapy $w p $a viroterapia onkolytická 665 $a 2006, 1966-1993; use VIRUSES 1994-2005 $2 eng 665 $a Viruses (1999-2005) $2 eng 680 9-
$i Tumor-selective, replication competent VIRUSES that have antineoplastic effects. This is achieved by producing cytotoxicity-enhancing proteins and/or eliciting an antitumor immune response. They are genetically engineered so that they can replicate in CANCER cells but not in normal cells, and are used in ONCOLYTIC VIROTHERAPY. $2 eng 680 $a ONCOGENIC VIRUSES is available $2 eng 750 -2
$a Oncolytic Viruses $2 eng 980 $x M
Number of the records: 1